Evoke Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,654 | $2,551 | $1,735 | $1,675 |
Gross Profit | 2,550 | 2,509 | 1,642 | 1,616 |
EBITDA | -1,285 | -1,142 | -1,861 | -1,887 |
EBIT | -2,366 | -3,749 | -3,775 | |
Net Income | -1,312 | -1,267 | -1,579 | -1,987 |
Net Change In Cash | 2,654 | 2,551 | 1,735 | 1,675 |
Free Cash Flow | -818 | -820 | -2,579 | -1,106 |
Cash | 11,339 | 9,177 | 9,702 | 4,739 |
Basic Shares | 1,399 | 1,363 | 756 | 3,343 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,180 | $2,508 | $1,618 | $23 |
Gross Profit | 4,978 | 2,138 | 1,289 | -63 |
EBITDA | -7,292 | -7,724 | -8,037 | -13,041 |
EBIT | -7,430 | -15,510 | -16,189 | -26,089 |
Net Income | -7,792 | -8,162 | -9,029 | -13,261 |
Net Change In Cash | 5,180 | 2,508 | 1,618 | 23 |
Cost of Revenue | 2,405 | |||
Free Cash Flow | -4,984 | -6,595 | -12,352 | -6,630 |
Cash | 4,739 | 9,843 | 9,144 | 8,068 |
Basic Shares | 278 | 261 | 223 | 177 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.94 |
2024-06-30 | -$0.92 |
2024-03-31 | -$0.17 |
2023-12-31 | -$0.59 |
